FindTrial
Sign In

the hemostatic effect between topical and intravenous use of tranexamic acid in the first total hip arthroplasty: a case records based retrospective study

the hemostatic effect between topical and intravenous use of tranexamic acid in the first total hip arthroplasty: a case records based retrospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORC-17014120
Enrollment
Unknown
Registered
2017-12-24
Start date
2017-12-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the use of tranexamic acid in the first total hip arthroplasty

Interventions

intravenous group vs topical group vs none-use group:tranexamic acid vs blank

Sponsors

the Second Affiliated Hospital Of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: The patients undergoing first THA from January 2014 to May 2017 were retrospected

Exclusion criteria

Exclusion criteria: (1) renal failure history and accepted renal-transplant; (2) history of vascular thrombosis including the myocardial infarction or cerebral infarction; (3) allergic to TXA; (4) anticoagulation by warfarin before going to the hospital; (5) hematological diseases such as coagulation disorders(history of Deep Venous Thrombosis (DVT) or Pulmonary Embolism (PE)); (6) simultaneous bilateral THA.

Design outcomes

Primary

MeasureTime frame
The Hb changes;Total blood loss;Transfusion rate;Complications;—

Countries

China

Contacts

Public ContactLei Shen

The Second Affiliated Hospital of Soochow University

slxytbien@163.com+86 13773826574

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026